In an email obtained by Inside Medicine from a former NIH contractor who received it, Memoli instructed his staff to "hold on ...

After a Saturday email from the Trump administration's Department of Government Efficiency (DOGE) team sparked anxiety among ...

A new memo by NIH Acting Director Matthew Memoli, obtained by Forbes, clarifies what can and can’t be done with regard to clinical trials, purchasing, research publications and public appearances.

HHS Secretary Robert F. Kennedy Jr. is reportedly ordering his staff to comply with the email request from Elon Musk for ...

The sudden policy change is that the NIH is to cap indirect cost recovery at 15 percent of the direct costs of a grant, ...

A memo from the NIH's acting director indicated research and clinical studies that began prior to Trump's inauguration can continue among the Trump administration's freeze on HHS activities.

Using an arcane law, officials have effectively delayed funding from the National Institutes of Health, leaving medical ...

Cuts to administrative costs associated with NIH grants could jeopardize the economic well-being of cities dependent on ...

Michael Lauer, deputy director of the National Institutes of Health’s extramural research, will leave the agency at the end ...

A federal judge issued a temporary restraining order against the National Institutes of Health, marking the latest successful ...

A two-day meeting aimed at raising awareness among policymakers and public about rare diseases scheduled for the end of the ...